5-(2,4-dichlorophenyl)-1H-pyrazole-4-carboxylic acid
- $240 - $972
- Product name: 5-(2,4-dichlorophenyl)-1H-pyrazole-4-carboxylic acid
- CAS: 1152543-53-7
- MF: C10H6Cl2N2O2
- MW: 257.07
- EINECS:
- MDL Number:MFCD19706867
- Synonyms:5-(2,4-dichlorophenyl)-1H-pyrazole-4-carboxylic acid;JR-14011, 3-(2,4-Dichlorophenyl)-1H-pyrazole-4-carboxylic acid, 97%;1H-Pyrazole-4-carboxylic acid, 3-(2,4-dichlorophenyl)-
4 prices
Selected condition:
Brand
- Crysdot
- TRC
Package
- 100mg
- 1g
- 5g
- 10g
- ManufacturerCrysdot
- Product numberCD11345948
- Product description5-(2,4-Dichlorophenyl)-1H-pyrazole-4-carboxylicacid 97%
- Packaging10g
- Price$972
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11345948
- Product description5-(2,4-Dichlorophenyl)-1H-pyrazole-4-carboxylicacid 97%
- Packaging5g
- Price$644
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11345948
- Product description5-(2,4-Dichlorophenyl)-1H-pyrazole-4-carboxylicacid 97%
- Packaging1g
- Price$337
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB420118
- Product description3-(2,4-Dichlorophenyl)-1H-pyrazole-4-carboxylicAcid
- Packaging100mg
- Price$240
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Crysdot | CD11345948 | 5-(2,4-Dichlorophenyl)-1H-pyrazole-4-carboxylicacid 97% | 10g | $972 | 2021-12-16 | Buy |
Crysdot | CD11345948 | 5-(2,4-Dichlorophenyl)-1H-pyrazole-4-carboxylicacid 97% | 5g | $644 | 2021-12-16 | Buy |
Crysdot | CD11345948 | 5-(2,4-Dichlorophenyl)-1H-pyrazole-4-carboxylicacid 97% | 1g | $337 | 2021-12-16 | Buy |
TRC | B420118 | 3-(2,4-Dichlorophenyl)-1H-pyrazole-4-carboxylicAcid | 100mg | $240 | 2021-12-16 | Buy |
Properties
Boiling point :455.1±40.0 °C(Predicted)
Density :1.580±0.06 g/cm3(Predicted)
pka :3.25±0.36(Predicted)
Density :1.580±0.06 g/cm3(Predicted)
pka :3.25±0.36(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|